Connect with us

Technology

10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting

Published

2 years ago

on

PLEASANTON, Calif., Oct. 1, 2024 /PRNewswire/ — At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, shared new details about its upcoming product roadmap and its ongoing strategy to democratize access to single cell analysis.

During its Foundational Sponsor talk in the Sept. 29 Technology Showcase, 10x Genomics announced an imminent plan to deliver “single cell for a single cent.” Through a series of new products and configurations expected to launch this quarter, 10x Genomics intends to deliver mega-scale single cell analysis at a cost as low as $0.01 per cell. 10x Genomics believes its upcoming launches, which enable 2.5 million cells per run and 5 million cells per kit, will be the most cost effective single cell products available for CRISPR screens, cell atlassing projects and other high-throughput applications.

“We know price is an important consideration, both for new researchers embarking on their first single cell experiment and current customers looking to do more – whether that’s analyzing more cells or more samples, or running more experiments, more routinely,” said Michael Schnall-Levin, Founding Scientist and Chief Technology Officer at 10x Genomics. “By continuing to deliver single cell technologies that offer superior performance and superior economics, we believe we can expand the single cell opportunity, drive widespread adoption and make single cell analysis the standard for most biological research.”

In addition to new solutions for mega-scale applications, 10x Genomics’ planned launches this quarter will feature cost effective products to increase access to and adoption of single cell in additional applications and use cases. These new offerings are expected to enable researchers to perform single cell experiments, even at a small scale, for approximately $560 per sample.

As part of the company’s strategy to democratize access to single cell analysis, 10x Genomics introduced several new products earlier this year to drive down customer cost in multiple directions: per cell, per sample, per experiment and per project. This includes:

Chromium GEM-X Technology: In March, 10x Genomics launched the first two products on its new GEM-X technology architecture, which enables increased sensitivity and capture efficiency, improved robustness and scalability and a more than two-fold reduction in cost per cell.

Chromium Xo: Last month, 10x Genomics announced the launch of Chromium Xo, the company’s most affordable single cell instrument. Chromium Xo delivers the high-quality data, superior reproducibility and ease of use that the company’s instrument-powered workflows are known for, at a U.S. list price of $25,000.

“For nearly a decade, researchers have known 10x as the single cell technology leader,” added Schnall-Levin. “Our upcoming launches will reinforce Chromium’s leadership in both high performance and low cost, because researchers should never have to compromise one for the other. We can’t wait to show the world what we’ve been working on.”

About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which fall under the “safe harbor” provisions of those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “might,” “will,” “should,” “expect,” “plan,” “anticipate,” “see,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding 10x Genomics, Inc.’s (“10x Genomics”) and others’ product launches, performance, configuration, costs, capabilities, requirements, workflows, applications, adoption, opportunities, leadership and pipeline. These statements are based on management’s current expectations, forecasts, beliefs, assumptions and information currently available to management, and actual outcomes and results could differ materially from these statements due to a number of factors. Other risks and uncertainties that could affect 10x Genomics’ financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents 10x Genomics files with the Securities and Exchange Commission (the “SEC”) from time to time. Although 10x Genomics believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to 10x Genomics as of the date hereof, and 10x Genomics disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing 10x Genomics’ views as of any date subsequent to the date of this press release.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-announces-mega-scale-single-cell-analysis-for-one-cent-per-cell-at-human-cell-atlas-general-meeting-302264693.html

SOURCE 10x Genomics, Inc.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

Published

4 hours ago

on

June 13, 2026

By

GOTHENBURG, Sweden, June 13, 2026 /PRNewswire/ — MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life sciences, is showcasing its latest advancements in sequencing, automation and clinical genomics at the European Society of Human Genetics (ESHG) 2026 Conference in Gothenburg, Sweden.

At Booth 352, MGI welcomes researchers, clinicians, laboratory leaders and industry partners to explore its comprehensive portfolio of sequencing and automation solutions while unveiling new initiatives designed to strengthen collaboration across the genomics ecosystem.

Advancing Clinical Genomics Through Partnership

A key highlight of ESHG 2026 is the launch of the MGI NGS Partner Enablement Program, a new initiative designed to connect diagnostic developers, assay providers and laboratory partners seeking to build validated clinical workflows on MGI sequencing platforms.

The program aims to accelerate the development and adoption of regulated next-generation sequencing (NGS) applications by fostering collaborations that simplify workflow implementation, reduce time-to-market and support broader access to precision medicine solutions.

“Clinical genomics is increasingly dependent on strong partnerships across the value chain,” said Fang Chen, General Manager Europe & Africa at MGI. “With the launch of our NGS Partner Enablement Program, we are creating a collaborative framework that brings together assay developers, software providers, automation partners and clinical laboratories to accelerate access to high-quality genomic testing.”

Expanding Automation Capabilities Through OEM Collaborations

At ESHG 2026, MGI is also announcing new Original Equipment Manufacturer (OEM) partnership opportunities on MGI’s DE Bundles (integrated library preparation and sequencing platform), bringing turnkey automation to global partners. The DE Bundle includes the current D4+E25 combination, as well as the new D16 paired with the E25 featuring a new 50M flow cell.

The D16, which will be launched later this year, is a benchtop, mid-to-low throughput library prep system and the upgraded successor to the D4. Retaining the fully enclosed contamination control system, it integrates a single-channel robotic pipetting module to maximize automation. With two sample preparation cartridges each processing 8 samples, the D16 delivers significantly higher throughput. The D16 and E25 systems provide flexible and scalable automation solutions for library construction, sequencing, bioinformatics analysis, streamlining the entire laboratory workflow.

Through this open OEM framework, MGI is enabling customers and solution providers to integrate proven automation technologies into customized workflows tailored to specific clinical and research applications. The OEM program reflects MGI’s commitment to building an open ecosystem that empowers laboratories to increase efficiency, improve standardization and accelerate scientific discovery.

“We are excited to expand the opportunities available to our OEM partners by providing access to the D16 platform, enabling the development of truly walkaway solutions that simplify and automate complex laboratory workflows,” said Wim Vervaeke, OEM Director at Europe & Africa at MGI. “Our innovations, including the PrepALL, E25, and G99, have already sparked new partnerships across the life sciences ecosystem. By combining MGI’s automation expertise with the specialized capabilities of our partners, we are creating integrated solutions that deliver maximum value, efficiency, and convenience for end users.”

Corporate Satellite Symposium Highlights Clinical Genomics, Precision Oncology and Spatial Multi-Omics

As part of ESHG 2026, MGI hosted its Corporate Satellite Symposium, Advancing Diagnostics: From Clinical Implementation to Biomarker Discovery, bringing together leading experts from across Europe to showcase how advanced genomic technologies are being translated into real-world clinical and research impact. The symposium highlighted applications spanning clinical oncology diagnostics, pharmacogenomics, and spatial multi-omics.

Dr. Raquel T. Lima from IPATIMUP (Portugal) presented the clinical value of RNA sequencing for detecting actionable gene fusions in solid tumours, improving diagnostic yield and supporting precision oncology decision-making. Prof. Dr. Andreas Braun from University Hospital Schleswig-Holstein (Germany) shared how spatial biology technologies map the tumour microenvironment in melanoma, revealing tumour heterogeneity, cellular interactions, and mechanisms associated with disease progression and treatment response. Dr. Andrea Conti from BMR Genomics (Italy) explored the opportunities of whole genome sequencing for pharmacogenetic marker evaluation, highlighting how comprehensive genomic approaches can support the implementation of personalised medicine through improved identification of clinically relevant variants.

Together, the presentations demonstrated how genomic and multi-omics technologies are advancing clinical diagnostics, translational oncology research, and precision medicine, while highlighting the growing role of sequencing in delivering actionable insights across healthcare and biomedical research.

Comprehensive Solutions for Genomics and Multi-Omics Research

Visitors to the MGI booth can explore the company’s comprehensive portfolio of sequencing and automation technologies supporting applications across human genetics, oncology, reproductive health, population genomics and multi-omics research.

Highlighting strong market adoption, MGI is showcasing the T7+, its ultra-high-throughput sequencing platform at the conference. Following its official launch for the Europe and Africa region at Analytica 2026 in Munich, the T7+ has gained significant momentum, with 27 units installed worldwide as of the end of 2025. From benchtop to ultra-high-throughput sequencing platforms, as well as advanced laboratory automation solutions, MGI continues to support laboratories seeking high-performance, scalable and cost-effective genomics workflows.

“Our mission extends beyond delivering innovative technologies,” said Dr. Christian Zimmerman, VP Sales Europe & Africa at MGI. “We are focused on building a complete ecosystem that enables our customers to transition seamlessly from research to clinical implementation. The partnerships and initiatives we are launching at ESHG 2026 demonstrate our commitment to making genomic technologies more accessible, integrated and impactful.”

Driving the Future of Precision Medicine in Europe

Europe remains a strategic region for MGI, with growing adoption of genomic technologies across research institutions, healthcare systems and national population initiatives.

Through continued investment in sequencing innovation, automation, clinical partnerships and collaborative ecosystem development, MGI is helping accelerate the transition toward more precise, data-driven healthcare.

As genomics increasingly becomes integrated into routine clinical practice, MGI remains committed to providing the technologies and partnerships necessary to support the next generation of precision medicine.

About MGI

MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries.

Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. As one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers, MGI empowers global users with scalable sequencing capabilities ranging from Gb to Tb levels. MGI also stands out as one of the only providers of a full-stack product portfolio that spans three core segments: SEQ ALL (short- and long-read sequencing), GLI (Generative Lab Intelligence), and Multi-Omics. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future.

To learn more, please visit MGI Tech, LinkedIn, X, Instagram, and YouTube.

 

View original content:https://www.prnewswire.co.uk/news-releases/mgi-tech-showcases-expanding-genomics-ecosystem-at-eshg-2026-with-new-ivd-partnering-program-and-oem-collaborations-302799622.html

Continue Reading

Technology

VEVOR Launches “Beat the Heat at Home” Summer Comfort Lineup for Outdoor Living

Published

7 hours ago

on

June 13, 2026

By

HOUSTON, June 13, 2026 /PRNewswire/ — As summer temperatures climb, staying cool at home shouldn’t require a sky-high electric bill, a cooler full of gas-station ice, or a contractor booked out until September. A smarter approach is gaining traction among American families: investing in the right tools to make outdoor living genuinely comfortable without the premium price tag. VEVOR — a trusted home improvement brand serving over 30 million home creators worldwide — today launches “Beat the Heat at Home,” a summer comfort lineup featuring shade, ice-making, and airflow solutions that deliver pro-level performance so your backyard truly becomes the place to be this summer.

“Summer comfort is not only about staying cool — it is about making outdoor spaces easier to enjoy,” said Gavin Wu, Brand Director at VEVOR. “With this lineup, VEVOR brings pro-level performance into practical home scenarios, helping Home Creators upgrade their backyards, patios, garages, and hosting spaces at exceptional value.”

Cool Living, Cold Drinks, Total Comfort
For most families, a truly comfortable summer day comes down to three things: a shady spot, a steady supply of ice-cold drinks, and enough airflow to keep the evening from feeling stagnant. Traditional solutions — pergolas, commercial ice machines, wired-in fans — often cost thousands or require contractors.

To bridge this gap, VEVOR’s Annual Big Summer Sale officially introduces the “Beat the Heat” collection. Together, the lineup addresses three common summer comfort needs: shade, ice, and airflow, so every corner of the backyard is covered. By delivering pro-level performance in effortless, budget-friendly setups, VEVOR offers Home Creators the ultimate plug-and-play summer cooling experience, making premium seasonal comfort accessible right out of the box.

Create Shade in Minutes
There’s a specific moment every summer host knows too well: the sun shifts, the one shady corner disappears, and suddenly everyone is squinting, relocating chairs, or retreating indoors altogether. It’s the kind of small frustration that quietly ruins an otherwise perfect afternoon.

VEVOR’s Pop-Up Canopy Gazebo was designed for exactly that moment. Available in 10×10, 11.5×11.5, and 12×12 ft configurations, it turns any open stretch of lawn or driveway into a comfortable, shaded gathering space — and it does so in minutes — designed for tool-free setup from the start. The mesh sidewalls earn their keep once evening arrives: mosquitoes stay out while the breeze still flows through, which means dinner can linger as long as the conversation does.

It’s not a permanent structure, and that’s the point. When the season changes or the party moves, the canopy folds back down just as quickly. For homeowners who want shade on their terms, not on a contractor’s timeline, it offers a flexible alternative to permanent shade structures.

Never Run Out of Ice
Few things signal “this gathering is winding down” faster than reaching into a cooler and finding nothing but lukewarm water and half-melted slush. Bags of store-bought ice solve the problem temporarily, but anyone who has made two mid-party runs to the gas station knows the drill gets old fast.

VEVOR’s Commercial Ice Maker Machine helps home hosts keep up with high-demand summer gatherings. Producing up to 130 lbs of ice every 24 hours and holding 33 lbs in its built-in storage bin, it keeps pace with a full afternoon of refills — lemonade pitchers, cocktail shakers, coolers for the kids’ juice boxes, all of it. The stainless-steel build looks at home in a garage bar or outdoor kitchen, and one-touch self-cleaning means maintenance is measured in button presses, not scrub sessions.

Keep the Air Moving
Anyone who has spent a July evening on a covered porch knows the paradox: the roof blocks the sun, but it also traps every degree of rising heat with nowhere to go. The air sits heavy, the ceiling feels lower than it is, and even a beautiful outdoor space starts to feel like something you’d rather admire from behind a glass door with the AC running inside.

VEVOR’s 18-Inch Wall-Mount Fan was built for exactly these in-between spaces that central air can’t reach and a tabletop fan can’t handle. Three-speed settings push up to 4,150 CFM of airflow across patios, enclosed porches, workshops, and garage gyms. That’s the kind of serious air movement that makes a covered space feel open again. With ETL certification and weather-resistant construction, it is designed for covered or semi-outdoor spaces where moisture and humidity are common.

Mounted on the wall and out of the way, it doesn’t eat into floor space or crowd a table. For households looking to cut back on running central AC in every room all day, a well-placed fan in the spaces where the family actually gathers is often the simplest and most cost-effective first step.

The deals are live — don’t leave them on the table.

Cool your summer now: vevor.com/summer-cooling

Shop VEVOR’s Summer Sale: vevor.com/summer-sale

Visit in person: VEVOR Houston Store: 10951 Farm to Market 1960 Road W, Houston

Summer won’t wait. Neither should your backyard. More deals, more summer-ready upgrades — all waiting for you.

About VEVOR
Pro-Level Performance Without the Pro-Level Price. VEVOR is a home improvement brand built for Home Creators who want to upgrade their spaces with practical, high-performing products at exceptional value. From outdoor living and tools to home improvement equipment and everyday project essentials, VEVOR helps people take on upgrades with confidence, efficiency, and value.

Today, VEVOR operates in over 50 countries, supported by a network of 200+ global warehouses and a catalog of more than 15,000 SKUs spanning tools, outdoor equipment, and home improvement solutions. VEVOR has supported over 30 million Home Creators worldwide, bringing performance, inspiration, and value to their home improvement projects. For more information, visit www.vevor.com. VEVOR products are also available on Amazon.

Media Contact
VEVOR Communications Team
media@vevor.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vevor-launches-beat-the-heat-at-home-summer-comfort-lineup-for-outdoor-living-302797877.html

SOURCE VEVOR

Continue Reading

Technology

YEEDI Delivers Lowest-Ever Pricing on Self-Cleaning Roller Mop Robot Vacuums With Early Prime Day Deals

Published

7 hours ago

on

June 13, 2026

By

Starting June 13, M14 PLUS and S14 PLUS Drop to $399.99, Bringing Advanced Self-Cleaning Roller Mop Technology Into the Sub-$400 Segment

SAN FRANCISCO, June 13, 2026 /PRNewswire/ — YEEDI, a home cleaning technology brand focused on practical innovation and high-performance smart home solutions, is kicking off Prime Day early by offering its M14 PLUS and S14 PLUS at their lowest prices ever. Starting June 13, both self-cleaning roller mop robot vacuums are available for just $399.99, allowing shoppers to secure Prime Day pricing ahead of the broader promotional event.

The promotion marks a significant milestone for the category, bringing advanced self-cleaning roller mop technology into the sub-$400 segment and making one of the industry’s most sought-after cleaning innovations more accessible than ever before. As part of YEEDI’s “Less Time Cleaning. More Time Playing.” campaign, inspired by a summer of sports, family moments, and everyday adventures, the brand aims to help consumers spend less time on household chores and more time enjoying the moments that matter most. Complete offer details are available at YEEDI.com.

Bringing Premium Roller Mop Technology to More Homes

Roller mop technology has emerged as one of the most significant innovations in robotic floor cleaning, offering continuous scrubbing performance while automatically cleaning the mop during operation. However, robot vacuums equipped with self-cleaning roller systems have traditionally remained concentrated in premium price segments.

By bringing the M14 PLUS and S14 PLUS to $399.99, YEEDI is expanding access to one of the industry’s most advanced floor-cleaning technologies and establishing a new affordability benchmark for self-cleaning roller mop robot vacuums.

YEEDI M14 PLUS Reaches Its Lowest Price Ever

Available for $399.99 (regularly $599.99), the YEEDI M14 PLUS combines the brand’s OZMO Roller mopping technology with ZeroTangle anti-tangle technology to deliver powerful wet and dry cleaning while minimizing maintenance.

The robot is paired with an automated OMNI Station that handles dust collection, hot-water mop washing, and hot-air drying, reducing the need for manual upkeep. Designed for busy households seeking a hands-free cleaning experience, the M14 PLUS now offers premium functionality at an unprecedented value.

YEEDI S14 PLUS Delivers Flagship Cleaning at 67% Off

Available for $399.99 (regularly $1,199.99), the YEEDI S14 PLUS reaches its lowest price in history and represents one of the most compelling values in the premium robot vacuum category.

Winner of the CES 2025 Indoor Cleaning Technology Innovation Gold Award, the S14 PLUS combines YEEDI’s advanced OZMO Roller system and TruEdge 2.0 Adaptive Edge Cleaning technology for enhanced stain removal and edge-to-edge coverage.

Equipped with 18,000 Pa suction power and ZeroTangle 2.0 technology, the S14 PLUS delivers a flagship cleaning experience at a price point rarely seen in the premium robot vacuum market.

More Prime Day Deals Arrive June 23–26

Following the early access promotion, YEEDI will extend Prime Day deals across a broader selection of robot vacuums from June 23 through June 26, giving consumers even more opportunities to upgrade their home cleaning experience.

Featured offers include the YEEDI M16 Infinity at $449.99 (44% off), the YEEDI S20 Infinity at $699.99, the YEEDI S20 Infinity Ultra at $849.99, and the YEEDI S16 PLUS at $449.99. YEEDI will also introduce two new models: the M12 PRO Gen2 at an introductory price of $339.99 and the C14 PRO PLUS at $279.99.

Consumers can visit YEEDI.com to explore full Prime Day deals, and discover how YEEDI’s smart cleaning technology helps them spend less time cleaning and more time enjoying everyday life.

About YEEDI

YEEDI is a home cleaning technology brand dedicated to making advanced robotic vacuum technology practical, reliable, and accessible for everyday households. Guided by its philosophy of Accessible Innovation, YEEDI focuses on delivering powerful, user-friendly cleaning solutions that prioritize real-world usability, low maintenance, and long-term value.

View original content to download multimedia:https://www.prnewswire.com/news-releases/yeedi-delivers-lowest-ever-pricing-on-self-cleaning-roller-mop-robot-vacuums-with-early-prime-day-deals-302798950.html

SOURCE YEEDI Technology

Continue Reading

Trending